Stock Rich List
Nasdaq: AMRX

Amneal Pharmaceuticals insiders

The officers, directors and 10% owners of Amneal Pharmaceuticals, Inc. who hold the most stock, valued at the live AMRX price.

$21.39
AMRX today −$490K (−2.24%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
14
Their AMRX stock
$3.18B
Market value
$7.45B
Held by ranked insiders
42.7%

Insiders by value of AMRX holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Tushar Patel10% owner61,341,678$1.31B17.6%207th
2Chintu PatelCo-CEO29,332,640$627M8.42%404th
3Dipan PatelInsider26,905,073$575M7.72%441st
4Chirag K. PatelPresident & Co-CEO25,853,757$553M7.42%460th
5Gautam PatelDirector1,927,595$41.2M0.55%2837th
6Paul M. MeisterDirector832,800$17.8M0.24%4501st
7Tasos KonidarisExecutive Vice President & CFO449,434$9.6M0.13%9053rd
8Jeffrey P. GeorgeDirector344,614$7.4M<0.1%10705th
9Joseph TodiscoExecutive Vice President327,194$7.0M<0.1%7987th
10Ted C. NarkDirector325,848$7.0M<0.1%11432nd
11Shlomo YanaiDirector320,804$6.9M<0.1%9703rd
12J. Kevin BuchiDirector282,520$6.0M<0.1%12088th
13Nikita ShahExecutive Vice President253,390$5.4M<0.1%13685th
14Emily Peterson AlvaDirector211,029$4.5M<0.1%13113th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Amneal Pharmaceuticals; see each profile for the filing.